scispace - formally typeset
C

Claire Bardel

Researcher at University of Lyon

Publications -  61
Citations -  865

Claire Bardel is an academic researcher from University of Lyon. The author has contributed to research in topics: Medicine & Gene. The author has an hindex of 15, co-authored 54 publications receiving 658 citations. Previous affiliations of Claire Bardel include French Institute of Health and Medical Research & Claude Bernard University Lyon 1.

Papers
More filters
Journal ArticleDOI

Solid lipid nanoparticles suspension versus commercial solutions for dermal delivery of minoxidil

TL;DR: Solid lipid nanoparticles suspensions were shown as efficient as commercial solutions for skin penetration and were non-corrosive while commercial solutions presented a corrosive potential; and would constitute a promising formulation for hair loss treatment.
Journal ArticleDOI

On the use of haplotype phylogeny to detect disease susceptibility loci

TL;DR: Under models where the susceptibility to the disease is caused by a single genetic variant, the cladistic test is neither really more powerful to detect an association nor really more efficient to localize the susceptibility site than an individual SNP testing, however, when two interacting sites are responsible for the disease, thecladistic analysis greatly improves the probability to find the two susceptibility sites.
Journal ArticleDOI

Whole genome paired-end sequencing elucidates functional and phenotypic consequences of balanced chromosomal rearrangement in patients with developmental disorders.

TL;DR: Next-generation sequencing used to characterise breakpoints of balanced chromosomal rearrangements at the molecular level in patients with intellectual disability and/or congenital anomalies suggested that DNA breaks arose randomly and that there was no major influence of repeated elements.
Journal ArticleDOI

A genetic schizophrenia-susceptibility region located between the ANKK1 and DRD2 genes.

TL;DR: Intergenic rs2242592 appears to be involved in the genetic vulnerability to schizophrenia, whereas the ANKK1 rs1800497 appears to have a modifying rather than causative effect.